Wellington Management Group’s Avalyn Pharma AVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$60M Sell
2,104,859
-97,127
-4% -$3.13M 0.01% 666
2026
Q2
$72.5M Buy
+2,201,986
New +$63.5M 0.01% 635

Other funds holding AVLN

Wellington Management Group's AVLN Position: Q3 2026 in Review

Wellington Management Group reduced its Avalyn Pharma (AVLN) stake by 4.4% in Q3 2026, selling an estimated $3.13M and leaving 2,104,859 shares worth $60M. The position accounts for 0.01% of the portfolio, ranked #666.

Wellington Management Group first reported a position in AVLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $72.5M in Q2 2026. 116 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.

  • Wellington Management Group held 2,104,859 shares of Avalyn Pharma worth $60M as of Q3 2026.
  • Wellington Management Group sold 97,127 Avalyn Pharma shares in Q3 2026, an estimated $3.13M.
  • Avalyn Pharma made up 0.01% of Wellington Management Group's portfolio in Q3 2026, its #666 holding.
  • Wellington Management Group first reported a position in Avalyn Pharma in Q2 2026 and has held it in 2 quarters since.
  • Wellington Management Group's Avalyn Pharma position peaked at $72.5M in Q2 2026.
  • 116 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.

Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.